Michelle T. Lee, MD

Cardiology Fellow @BCMHeart @IQuEStHouston | Alumnus @UTHealth

[Michelle T. Lee, MD @MTLeeMD]

Young women with premature #ASCVD and #IHD receive less antiplatelets and statins compared with men with lower adherence to statins -from the Veterans wIth premaTure AtheroscLerosis (VITAL) registry @JAMACardio @Iquesthouston @BCMHeart @virani_md @Dmahtta
https://t.co/aPxSsbao10

[IQuESt @IQuEStHouston]

Congratulations to our 2022 graduating fellowship class 👏 We can't wait to see what the future holds!

[Jamal Rana, MD @JamalRanaMD]

@ACCinTouch @MTLeeMD @MTLeeMD is a ⭐️ #Fit #WIC , thank you @virani_md for connecting as it was great to work with her and thank you @DrNathanWong & @MichaelJBlaha for the invite . @DrMarthaGulati @aayshacader @DrToniyaSingh @mcwlovesheart

[American College of Cardiology @ACCinTouch]

A recent study found that presence of #Diabetes was found to be a #CVD risk equivalent in one-fifth of CVD-free adults living with diabetes. Check out the expert analysis by @MTLeeMD & @JamalRanaMD to learn more: https://t.co/PyhCe0OJiv #cvMetabolic

[Salim Virani @virani_md]

Clinically important paper by @jia_xiaoming showing predictors of SASE in large healthcare system (>1.2 million ASCVD patients) but importantly, which patients do or don't receive mod/high-intensity statins despite SASE👇
https://t.co/6RCnEyAFbY

[Salim Virani @virani_md]

@MTLeeMD @dmahtta @Ingeniero_TX @ShahabHunaina @mahrifai Excellent resource for anyone wanting to have a quick read on studies presented at #ESC2021 Strong work @MTLeeMD @ShahabHunaina @mahrifai @Ingeniero_TX @dmahtta @BCMHeart @IQuEStHouston

[Michelle T. Lee, MD @MTLeeMD]

Excited to share our review highlighting late breaking science and advancements in CV prevention presented at #ESC2021

https://t.co/4hikEEaxxZ

@virani_md @dmahtta @Ingeniero_TX @ShahabHunaina @mahrifai

[IQuESt @IQuEStHouston]

Want to talk productivity? PubMed-based algorithms placed Dr. @virani_md in the top 0.01% of scholars writing about Cholesterol over the past 10 years, a level that they label as "World Expert". 👏😲
https://t.co/VvxcyVDTxD

[Dhruv Mahtta @dmahtta]

Increased emphasis & utilization of #telehealth services during #COVID19 pandemic. Will this modality of providing #Quality #healthcare continue to prevail in the future? @virani_md @shishem @SaleemSayani @MarilyneDaher1 @MTLeeMD @BCMHeart https://t.co/qYo473XUN5

[Aliza Hussain, MD @AlizaHussainMD]

Thank you @virani_md @JamalRanaMD @MTLeeMD for contributing to our review article on an imp topic. Stroke 📈 in the young, with ⬆️ in traditional and nontraditional RF (e.g recreational drugs). While ASA/statins use much ⬇️ in pts w/ premature ASCVD. 🕛 to address these issues!

[Jamal Rana, MD @JamalRanaMD]

Our Paper "Epidemiology and risk factors for stroke in young individuals: implications for prevention" in Curr Opinion Cardiol is out. Aliza Hussain, @MTLeeMD, @virani_md
7 key points 🧵
1. Rising incidence of stroke in young adults, with largest increase in ischemic strokes.

[IQuESt @IQuEStHouston]

Association of premature atherosclerotic cardiovascular disease with higher risk of cancer: a behavioral risk factor surveillance system study ⬇️@MTLeeMD @dmahtta @virani_md @BCMHeart @vahsrd
https://t.co/kEBveTapbO

[American College of Cardiology @ACCinTouch]

A new @JAMACardio study highlights significant #healthdisparities in CV care between women and men #veterans with premature and extremely premature atherosclerotic #CVD. Learn more: https://t.co/m2TNbdqyrL @MTLeeMD

[Michelle T. Lee, MD @MTLeeMD]

@UTHHeart @EGarciaSayan @McGovernMed @UTHealth Congrats @EGarciaSayan !

[Umair Khalid @Umair2017]

Excited to share my 1st senior author publication in JAMA, on Oral Anti-platelet Therapy in ACS (review)!

Link: https://t.co/bWoHBelUDx
My recorded podcast: https://t.co/L0S5LKfMLm

@JAMA_current @WKayaniMD @virani_md @vijay_nambi @docHJ #ACCEarlyCareer #CardioTwitter #ACCFIT

[TCTMD @TCTMD]

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short https://t.co/P77OH3JMw7

[[email protected] @medresearchnews]

https://t.co/ZiH30eb4lC Interview with:

First Author

Michelle Lee, MD, PharmD
Fellow-in-training, Health Services Research & Development
Michael E. DeBakey VA Medical Center, Houston, TX

Senior & Corresponding Author
Salim S. #@heartdisease

https://t.co/yYxjObtQiE

[Michelle T. Lee, MD @MTLeeMD]

We need to do better! ❤️Recent news: Women are less likely to receive Preventive Cardiovascular & Stroke care vs. men. https://t.co/1OmZrGj8um

@womenshealth @DrJAshton @WomensHealthMag @WHA @BarbraStreisand @AmerMedicalAssn @NPRHealth @TheHeartTruth @HeartNews @MillionHeartsUS

[Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 @DrMarthaGulati]

@DeptVetAffairs @VeteransHealth @JAMACardio
WE need to ensure women and men veterans (and really anyone for that matter) get the GDMT that are Class I recommendations. There is no reason for this. Need good preventive care @ASPCardio @WomensHeartCS @WomenHeartOrg @WomenAs1

[Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 @DrMarthaGulati]

@DeptVetAffairs @VeteransHealth @JAMACardio
WE need to ensure women and men veterans (and really anyone for that matter) get the GDMT that are Class I recommendations. There is no reason for this. Need good preventive care @ASPCardio @WomensHeartCS @WomenHeartOrg @WomenAs1

[Michelle T. Lee, MD @MTLeeMD]

@Nate_WilsonMD @FrontiersIn Congrats @Nate_WilsonMD! Thanks for including me in this important work!

[Nate Wilson @Nate_WilsonMD]

New publication from our team:
💥In high risk patients with cancer-related pericardial effusion, pericardiocentesis is safe and effective, with low complication rates even in cases with severe thrombocytopenia and hemodynamic instability
https://t.co/k6WYGuID2R @FrontiersIn